Back to Search Start Over

Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania

Authors :
Ishengoma, Deus S.
Mandara, Celine I.
Madebe, Rashid A.
Warsame, Marian
Ngasala, Billy
Kabanywanyi, Abdunoor M.
Mahende, Muhidin K.
Kamugisha, Erasmus
Kavishe, Reginald A.
Muro, Florida
Mandike, Renata
Mkude, Sigsbert
Chacky, Frank
Njau, Ritha
Martin, Troy
Mohamed, Ally
Bailey, Jeffrey A.
Fola, Abebe A.
Ishengoma, Deus S.
Mandara, Celine I.
Madebe, Rashid A.
Warsame, Marian
Ngasala, Billy
Kabanywanyi, Abdunoor M.
Mahende, Muhidin K.
Kamugisha, Erasmus
Kavishe, Reginald A.
Muro, Florida
Mandike, Renata
Mkude, Sigsbert
Chacky, Frank
Njau, Ritha
Martin, Troy
Mohamed, Ally
Bailey, Jeffrey A.
Fola, Abebe A.
Publication Year :
2024

Abstract

Background: Tanzania is currently implementing therapeutic efficacy studies (TES) in areas of varying malaria transmission intensities as per the World Health Organization (WHO) recommendations. In TES, distinguishing reinfection from recrudescence is critical for the determination of anti-malarial efficacy. Recently, the WHO recommended genotyping polymorphic coding genes, merozoite surface proteins 1 and 2 (msp1 and msp2), and replacing the glutamate-rich protein (glurp) gene with one of the highly polymorphic microsatellites in Plasmodium falciparum to adjust the efficacy of antimalarials in TES. This study assessed the polymorphisms of six neutral microsatellite markers and their potential use in TES, which is routinely performed in Tanzania. Methods: Plasmodium falciparum samples were obtained from four TES sentinel sites, Kibaha (Pwani), Mkuzi (Tanga), Mlimba (Morogoro) and Ujiji (Kigoma), between April and September 2016. Parasite genomic DNA was extracted from dried blood spots on filter papers using commercial kits. Genotyping was done using six microsatellites (Poly-alpha, PfPK2, TA1, C3M69, C2M34 and M2490) by capillary method, and the data were analysed to determine the extent of their polymorphisms and genetic diversity at the four sites. Results: Overall, 83 (88.3%) of the 94 samples were successfully genotyped (with positive results for >= 50.0% of the markers), and > 50.0% of the samples (range = 47.6-59.1%) were polyclonal, with a mean multiplicity of infection (MOI) ranging from 1.68 to 1.88 among the four sites. There was high genetic diversity but limited variability among the four sites based on mean allelic richness (R-S = 7.48, range = 7.27-8.03, for an adjusted minimum sample size of 18 per site) and mean expected heterozygosity (H-e = 0.83, range = 0.80-0.85). Cluster analysis of haplotypes using STRUCTURE, principal component analysis, and pairwise genetic differentiation (F-ST) did not reveal population structure or clustering of par

Details

Database :
OAIster
Notes :
application/pdf, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1430675323
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.1186.s12936-024-04901-6